Park Medi World, the operator of the well-known Park Hospital chain in North India, is all set to enter the stock market with a ₹920 crore Initial Public Offering (IPO) opening on 10 December 2025. The shares have been priced in a band of ₹154 to ₹162 per share, and the subscription window will close on 12 December 2025.
The IPO is structured as a combination of a fresh issue worth ₹770 crore and an offer-for-sale (OFS) of ₹150 crore by the company’s promoters. Investors can apply for a minimum of 92 shares, with further applications in multiples of 92 shares. If the listing goes ahead as planned, Park Medi World is expected to debut on the stock exchanges on 17 December 2025, giving it an estimated valuation of around ₹7,000 crore.
The company plans to use the proceeds from the IPO for multiple strategic purposes. About ₹380 crore will be directed towards repaying existing borrowings, which were reported at ₹624.3 crore as of October 2025. Around ₹60.5 crore will be invested in developing a new hospital under Park Medicity in the NCR region and expanding an existing facility managed by its subsidiary, Blue Heavens. Another ₹27.4 crore will be used to purchase medical equipment across its hospitals, while the remaining funds will support general corporate purposes and potential future acquisitions.
Park Medi World operates 13 multi-specialty, NABH-accredited hospitals across North India, including Haryana, Delhi, Punjab, and Rajasthan, with a combined capacity of approximately 3,000 beds. The chain has earned a reputation for quality healthcare services, particularly in multi-specialty and critical care areas.
With this IPO, the company aims to strengthen its balance sheet, reduce debt, and expand its infrastructure, positioning itself for future growth in the region’s healthcare sector. For investors, this offering provides an opportunity to be part of one of North India’s largest private hospital networks at a crucial phase of expansion.
Also Read: RBI lowers repo rate to 5.25% for economic growth